首页> 外文期刊>Journal of Orthopaedic Translation >Use of a three-dimensional printed polylactide-coglycolide/tricalcium phosphate composite scaffold incorporating magnesium powder to enhance bone defect repair in rabbits
【24h】

Use of a three-dimensional printed polylactide-coglycolide/tricalcium phosphate composite scaffold incorporating magnesium powder to enhance bone defect repair in rabbits

机译:结合镁粉的三维印刷聚丙交酯-乙交酯/磷酸三钙复合支架在兔骨缺损修复中的应用

获取原文

摘要

BackgroundThe repair of large bone defects remains challenging for orthopaedic surgeons. Bone grafting remains the method of choice; such grafts fill spaces and enhance bone repair. Therapeutic agents also aid bone healing. The objective of this study is to develop a composite bioactive scaffold composed of polylactide-coglycolide (PLGA) and tricalcium phosphate (TCP) (the basic carrier) incorporating osteogenic, bioactive magnesium metal powder (Mg).MethodPorous PLGA/TCP scaffolds incorporating Mg were fabricated using a low-temperature rapid-prototyping process. We term the PLGA/TCP/Mg porous scaffold (hereafter, PPS). PLGA/TCP?lacking Mg served as the control material when evaluating the efficacy of PPS. A total of 36 New Zealand white rabbits were randomly divided into blank, PLGA/TCP (P/T) and PPS group, with 12 rabbits in each group. We established bone defects 15?mm in length in rabbit radii to evaluate thein?vivoosteogenic potential of the bioactive scaffold in terms of the direct controlled release of osteogenic Mg ion duringin?vivoscaffold degradation. Radiographs of the operated radii were taken immediately after implantation and then at 2, 4, 8 and 12 weeks. Micro-computed tomography of new bone formation and remaining scaffold and histological analysis were performed at 4, 8, 12 weeks after operation.ResultsX-ray imaging performed at weeks 4, 8 and 12 post-surgery revealed more newly formed bone within defects implanted with PPS and PLGA/TCP scaffolds than blank group (p < 0.05). And micro-computed tomography performed at weeks 4 and 8 after surgery revealed more newly formed bone within defects implanted with PPS scaffolds than PLGA/TCP scaffolds (p?
机译:背景技术对于骨科医生来说,大骨缺损的修复仍然具有挑战性。骨移植仍然是选择的方法。这样的移植物填充空间并增强骨修复。治疗剂还有助于骨骼愈合。本研究的目的是开发一种由聚乳酸-乙交酯(PLGA)和磷酸三钙(TCP)(基本载体)结合成骨性生物活性镁金属粉末(Mg)组成的复合生物活性支架。使用低温快速成型工艺制造。我们称PLGA / TCP / Mg多孔支架(以下称为PPS)。评估PPS的功效时,缺少PLGA / TCP的Mg作为对照材料。将36只新西兰大白兔随机分为空白,PLGA / TCP(P / T)和PPS组,每组12只。我们建立了兔defects骨长度为15?mm的骨缺损,以评估生物活性支架在活体内脚手架降解过程中直接控制成骨Mg离子的体内成骨潜力。植入后立即然后在第2、4、8和12周拍摄手术半径的X光片。术后第4、8、12周进行了新的骨形成和剩余支架的微计算机断层扫描,并进行了组织学分析。结果术后4、8和12周进行的X射线成像显示,植入了缺损的骨中有更多新形成的骨PPS和PLGA / TCP支架比空白组高(p <0.05)。而且在手术后第4和第8周进行的微计算机断层扫描显示,植入PPS支架的缺损内的新形成的骨比PLGA / TCP支架要多(p <0.05)。从组织学上看,PPS组比对照组具有更多的新矿化骨(p <0.05)。 PPS组和PLGA / TCP组的新骨面积(总植入物区域)增加在第4周时分别为19.42%和5.67%,在第8周时分别为48.23%和28.93%。在第8周时,PPS和PLGA / TCP组的总植入区域中剩余的支架材料百分比分别为53.30%和7.65%,在第12周时分别为20.52%和2.70%。 ;它具有良好的生物相容性,可能具有临床应用价值。本文的翻译潜力镁和β-磷酸三钙具有骨诱导作用。印刷具有骨诱导作用的新型骨复合支架对修复节段性骨缺损具有重要意义。这项研究评估了PPS在兔radius骨节段骨缺损模型中的功效。结果表明,具有良好生物相容性的新型支架可能是优良的移植物,并可能具有临床用途。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号